World's Best Scientists 2026 revealed!
James Tartaglia

James Tartaglia

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 73 2153 1976 85 77 209 16668

James Tartaglia publications per year

The chart shows the history of publications by James Tartaglia between 1981 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. James Tartaglia published across 45 years, from 1981 to 2025, averaging 5 papers a year. Output peaked at 20 publications in 2001. 2 of the 224 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1981 to 2025. Vertical axis: number of publications, 0 to 20. Peak 20 publications in 2001. 1981: 1 publication 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 1 publication 1987: 0 publications 1988: 0 publications 1989: 2 publications 1990: 0 publications 1991: 2 publications 1992: 7 publications 1993: 4 publications 1994: 4 publications 1995: 14 publications 1996: 6 publications 1997: 7 publications 1998: 9 publications 1999: 10 publications 2000: 19 publications 2001: 20 publications 2002: 7 publications 2003: 4 publications 2004: 6 publications 2005: 9 publications 2006: 2 publications 2007: 7 publications 2008: 7 publications 2009: 3 publications 2010: 4 publications 2011: 5 publications 2012: 6 publications 2013: 11 publications 2014: 2 publications 2015: 5 publications 2016: 8 publications 2017: 5 publications 2018: 5 publications 2019: 10 publications 2020: 4 publications 2021: 2 publications 2022: 3 publications 2023: 1 publication 2024: 1 publication 2025: 1 publication
1981 2025

224 publications in total across all disciplines

View publications per year as a table
James Tartaglia: publications per year, 1981 to 2025
Year Publications
1981 1
1982 0
1983 0
1984 0
1985 0
1986 1
1987 0
1988 0
1989 2
1990 0
1991 2
1992 7
1993 4
1994 4
1995 14
1996 6
1997 7
1998 9
1999 10
2000 19
2001 20
2002 7
2003 4
2004 6
2005 9
2006 2
2007 7
2008 7
2009 3
2010 4
2011 5
2012 6
2013 11
2014 2
2015 5
2016 8
2017 5
2018 5
2019 10
2020 4
2021 2
2022 3
2023 1
2024 1
2025 1
Total 224
Download as CSV

James Tartaglia publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where James Tartaglia sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 202–211 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 209 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178 209
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

James Tartaglia D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where James Tartaglia sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 72–73 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184 73
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

James Tartaglia is affiliated with Sanofi in France and has contributed to research primarily in the fields of Immunology and Microbiology, with a strong focus on Medicine. Their work spans various subfields including Virology, Molecular Biology, Infectious Diseases, Immunology, and Epidemiology.

The scientist's research topics encompass HIV Research and Treatment, HIV/AIDS Research and Interventions, vaccines and immunoinformatics approaches, Immune Cell Function and Interaction, Poxvirus research and outbreaks, Bacillus and Francisella bacterial research, and Herpesvirus Infections and Treatments.

Recent papers authored or co-authored by James Tartaglia include:

  • Faculty Opinions recommendation of Broadly neutralizing antibody-derived CAR-T cells reduce viral reservoir in HIV-1-infected individuals., 2021, Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk, 2022, The Journal of Infectious Diseases
  • Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial, 2020, The Lancet HIV
  • Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies, 2023, Vaccine
  • HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions, 2020, JCI Insight

The regular collaborators of James Tartaglia include Sorachai Nitayaphan, Faruk Sinangil, Nelson L. Michael, Merlin L. Robb, and Robert J. O'Connell, each having co-authored multiple publications with them.

James Tartaglia has published in venues such as Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature, The Journal of Infectious Diseases, Vaccine, The Lancet HIV, and JCI Insight.

Best Publications

  • NYVAC: a highly attenuated strain of vaccinia virus

    James Tartaglia;Marion E. Perkus;Jill Taylor;Elizabeth K. Norton

  • Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

    Denis Gaucher;René Therrien;Nadia Kettaf;Bastian R. Angermann

  • Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

    Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp

  • Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

    Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan

  • An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.

    Alexandre Harari;Pierre-Alexandre Bart;Wolfgang Stöhr;Gonzalo Tapia

  • Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

    David C. Montefiori;Chitraporn Karnasuta;Ying Huang;Hasan Ahmed

  • ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

    R. Pal;D. Venzon;N. L. Letvin;S. Santra

  • Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon

    E. Beattie;J. Tartaglia;E. Paoletti

  • Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.

    Elizabeth Beattie;Karen L. Denzler;James Tartaglia;Marion E. Perkus

  • TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR

    Heesung Park;Monique V. Davies;Jeffrey O. Langland;Hwai-Wen Chang

  • Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

    Mary Lou Clements-Mann;Kent Weinhold;Thomas J. Matthews;Barney S. Graham

  • Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

    Merlin L Robb;Supachai Rerks-Ngarm;Sorachai Nitayaphan;Punnee Pitisuttithum

  • The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer

    Laszlo Radvanyi;Devender Singh-Sandhu;Scott Gallichan;Corey Lovitt

  • Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial

    Raphael Gottardo;Robert T. Bailer;Bette T. Korber;S. Gnanakaran

  • A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

    Thomas G. Evans;Michael C. Keefer;Kent J. Weinhold;Mark Wolff

  • The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120

    Nicos Karasavvas;Erik Billings;Mangala Rao;Constance Williams

  • Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.

    Robert B. Belshe;Geoffrey J. Gorse;Mark J. Mulligan;Thomas G. Evans

  • Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.

    Jill Taylor;Randall Weinberg;James Tartaglia;Christopher Richardson;Christopher Richardson

  • Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.

    Zdenek Hel;Janos Nacsa;Elzbieta Tryniszewska;Wen-Po Tsai

  • Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

    Nicolas van Baren;Marie-Claude Bonnet;Brigitte Dréno;Amir Khammari

  • Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.

    Zdenek Hel;David Venzon;Monita Poudyal;Wen Po Tsai

Frequent Co-Authors

Philippe Moingeon
Philippe Moingeon Sanofi (France)
Enzo Paoletti
Enzo Paoletti Rensselaer Polytechnic Institute
David C. Montefiori
David C. Montefiori Duke University
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Guido Ferrari
Guido Ferrari Duke University
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Punnee Pitisuttithum
Punnee Pitisuttithum Mahidol University
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Sorachai Nitayaphan
Sorachai Nitayaphan Armed Forces Research Institute of Medical Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of healthcare professions, many of which require specialized nursing education. For those interested in rapidly advancing their nursing career, exploring a 12-month accelerated nursing programs can be a practical option. These programs allow individuals with a prior degree to quickly earn a Bachelor of Science in Nursing (BSN) and enter the healthcare workforce efficiently.

Entry-level nursing roles also connect closely with immunology fields, especially in patient care and disease management. Students may consider applying to easy admission LPN programs as a straightforward pathway to becoming licensed practical nurses, which serve as essential healthcare providers in many settings.

For those interested in advanced clinical roles, knowing what is the easiest NP program helps prospective students identify flexible and accessible nurse practitioner degrees. This is particularly relevant for careers that integrate immunological expertise within patient treatment plans.

Additionally, specializing in mental health as a Psychiatric Mental Health Nurse Practitioner (PMHNP) can complement immunological knowledge, especially in managing psychosomatic and autoimmune disorders. Programs like top psychiatric mental health nurse practitioner programs online offer excellent clinical placement opportunities that blend theoretical learning with hands-on experience.

Best Scientists Citing James Tartaglia

Trending Scientists

Recently Published Articles